These data implied that low dose of Digitoxin strongly effected on cells regardless of EGFR type, suggesting although Digitoxin had no selectivity for EGFR wild type and mutated NSCLC cells, is still useful in killing Gefitinib-resistance NSCLC cells. Here, EGFR is linked to non-small cell lung carcinoma.